![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Jiang Yi-Zhou Yu Ke-Da Zuo Wen-Jia Peng Wen-Ting Shao Zhi-Ming
Publisher: Blackwell Publishing
E-ISSN: 1097-0142|120|9|1329-1337
ISSN: 0008-543X
Source: Cancer, Vol.120, Iss.9, 2014-05, pp. : 1329-1337
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Improved QOL with capecitabine in breast cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 508, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Factors in Improved Survival from Paediatric Cancer
By Taub J.W.
Drugs, Vol. 56, Iss. 5, 1998-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Docetaxel regimen improves survival in early breast cancer
Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. :